Suven life sciences

Investing in beaten down Pharma in 2017-18 has given us two 30% + CAGR stocks

Dear Sir, If you have been reading our mails, you might be aware that we have been extensively focusing on beaten down stocks/sectors wherein the companies have strong balance sheets and will probably emerge stronger from this crisis. The thesis behind the same is simple: Since the bear market that started in Jan’18 and accentuated by covid-19 crisis, a lot of stocks have corrected to levels wherein the market is assuming that companies won’t survive. It is true that some…

Read More

Suven Life Sciences (NSE – SUVEN) – May’17 Alpha/Alpha Plus stock

Dear Members, We have released 28th May’17: Suven Lifesciences Ltd (NSE Code – SUVEN) – Alpha/Alpha Plus stock for May’17. For details and other updates, please log into the website at the following link – Detailed pdf report on the company can be accessed at the following link – Suven Lifesciences (NSE Code – SUVEN) – May17 Katalyst Wealth Alpha Report Note: For any queries, mail us at [email protected] Date: 28th May’17 CMP – 175.65 (BSE); 176.15 (NSE) Rating – Positive – 3% weightage; this…

Read More
Copy Protected by Chetan's WP-Copyprotect.